Literature DB >> 18243791

Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations.

Ewald Schröder1, Philip Eaton.   

Abstract

Exogenous H(2)O(2) is widely applied to cardiovascular tissues in order to elicit oxidant-dependent responses relevant to signalling and disease. Lower levels of endogenous H(2)O(2) are essential for normal physiological functioning and signalling, whereas higher levels are associated with disease. Within diseased tissues, concentrations in excess of 100 microM have been measured, though 1-15 microM appears to be the upper limit of the healthy physiological range. Analysing the kinetic constants and abundance of peroxidases suggests that they may, on occasion, encounter tissue H(2)O(2) concentrations as high as 1 mM. Extracellular application of 0.01-1 mM peroxide appears to be directly relevant to biology and broadly mimics the release of H(2)O(2) endogenously by growth factors and other effectors. However, the intracellular H(2)O(2) may only ever reach 1-15% of the applied exogenous concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243791     DOI: 10.1016/j.coph.2007.12.012

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  57 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

2.  Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

Authors:  Stephen L Archer; Glenn Marsboom; Gene H Kim; Hannah J Zhang; Peter T Toth; Eric C Svensson; Jason R B Dyck; Mardi Gomberg-Maitland; Bernard Thébaud; Aliya N Husain; Nicole Cipriani; Jalees Rehman
Journal:  Circulation       Date:  2010-06-07       Impact factor: 29.690

3.  A novel strategy for global analysis of the dynamic thiol redox proteome.

Authors:  Pablo Martínez-Acedo; Estefanía Núñez; Francisco J Sánchez Gómez; Margoth Moreno; Elena Ramos; Alicia Izquierdo-Álvarez; Elisabet Miró-Casas; Raquel Mesa; Patricia Rodriguez; Antonio Martínez-Ruiz; David Garcia Dorado; Santiago Lamas; Jesús Vázquez
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

4.  Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice.

Authors:  Steve Lancel; Fuzhong Qin; Shannon L Lennon; Jingmei Zhang; Xiaoyong Tong; Michael J Mazzini; Y James Kang; Deborah A Siwik; Richard A Cohen; Wilson S Colucci
Journal:  Circ Res       Date:  2010-05-27       Impact factor: 17.367

5.  Downregulation of IDH2 exacerbates H2O2-mediated cell death and hypertrophy.

Authors:  Hyeong Jun Ku; Jeen-Woo Park
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

6.  Differential effects of hypoxic and hyperoxic stress-induced hypertrophy in cultured chick fetal cardiac myocytes.

Authors:  Allison A Greco; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-29       Impact factor: 2.416

7.  H₂O₂ induces delayed hyperexcitability in nucleus tractus solitarii neurons.

Authors:  T D Ostrowski; E M Hasser; C M Heesch; D D Kline
Journal:  Neuroscience       Date:  2014-01-04       Impact factor: 3.590

8.  FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration.

Authors:  Changsun Yu; Bok-Seok Kim; Eunhee Kim
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

Review 9.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

Review 10.  Cellular signaling and NO production.

Authors:  Thomas Michel; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-01-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.